Table 1 Distribution of WHO scores according to the demographic and clinical characteristics of the 56 subjects
From: Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19
WHO score ≥ 5 (N = 27) | WHO score < 5 (N = 29) | p value | |
|---|---|---|---|
Sex | |||
Female, N (%) | 9 (33) | 17 (59) | 0.104 |
Male, N (%) | 18 (67) | 12 (41) | |
Age, years | |||
Mean ± SD | 66 (12) | 65 (19) | 0.856 |
< 65, N (%) | 13 (48) | 15 (52) | 0.074 |
65–75, N (%) | 10 (37) | 4 (14% | |
> 75, N (%) | 4 (15) | 10 (34) | |
Cardiovascular comorbidities | |||
No, N (%) | 22 (85) | 18 (72) | 0.451 |
Yes, N (%) | 4 (15) | 7 (28) | |
Opportunistic Infections | |||
No, N (%) | 7 (26) | 23 (79) | 0.000 |
Yes, N (%) | 20 (74) | 6 (21) | |
Death | |||
No, N (%) | 18 (67) | 28 (97) | 0.010 |
Yes, N (%) | 9 (33) | 1 (3) | |
D-dimero, median (IQR) | 2734 (733–8647) | 473 (205–2479) | 0.275 |
PCR, median (IQR) | 106 (27–209) | 9 (4–68) | 0.370 |
First COVID-19 test, median (IQR) | 24.5 (18–27) | 21.5 (15–30.5) | 0.257 |